Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rogier Versteeg

Showing results (11-20 of 143) with videos related to

Pageof 15
Sort By:
Plos One|April 5, 2013
Intratumour diversity of chromosome copy numbers in neuroblastoma mediated by on-going chromosome loss from a polyploid stateGisela Lundberg, Yuesheng Jin, Daniel Sehic, et al.
Genes, Chromosomes & Cancer|January 31, 2003
Rearrangements and increased expression of cyclin D1 (CCND1) in neuroblastomaJan J Molenaar, Peter van Sluis, Kathy Boon, et al.
Endocrinology|August 29, 2006
Regulation of type III iodothyronine deiodinase expression in human cell linesMonique H A Kester, George G J M Kuiper, Rogier Versteeg, et al.
Cancer Research|January 14, 2010
Silencing of SPRY1 triggers complete regression of rhabdomyosarcoma tumors carrying a mutated RAS geneGerben Schaaf, Mohamed Hamdi, Danny Zwijnenburg, et al.
Plos One|October 22, 2011
Joint binding of OTX2 and MYC in promotor regions is associated with high gene expression in medulloblastomaJens Bunt, Nancy E Hasselt, Danny A Zwijnenburg, et al.
European Journal of Cancer (Oxford, England : 1990)|November 18, 2011
Targeted BIRC5 silencing using YM155 causes cell death in neuroblastoma cells with low ABCB1 expressionFieke Lamers, Linda Schild, Jan Koster, et al.
Acta Neuropathologica|November 27, 2012
OTX2 sustains a bivalent-like state of OTX2-bound promoters in medulloblastoma by maintaining their H3K27me3 levelsJens Bunt, Nancy A Hasselt, Danny A Zwijnenburg, et al.
Cancer Research|February 5, 2013
FOXO3a is a major target of inactivation by PI3K/AKT signaling in aggressive neuroblastomaEvan E Santo, Peter Stroeken, Peter V Sluis, et al.
Cancer Research|April 19, 2005
Inhibition of a new differentiation pathway in neuroblastoma by copy number defects of N-myc, Cdc42, and nm23 genesLinda J Valentijn, Arjen Koppen, Ronald van Asperen, et al.
Nucleic Acids Research|April 12, 2007
Comparison of RNAi efficiency mediated by tetracycline-responsive H1 and U6 promoter variants in mammalian cell linesJørn R Henriksen, Cecilie Løkke, Martin Hammerø, et al.
Pageof 15

Showing results (11-20 of 143) with videos related to

Sort By:
Pageof 15
Plos One|April 5, 2013
Intratumour diversity of chromosome copy numbers in neuroblastoma mediated by on-going chromosome loss from a polyploid stateGisela Lundberg, Yuesheng Jin, Daniel Sehic, et al.
Genes, Chromosomes & Cancer|January 31, 2003
Rearrangements and increased expression of cyclin D1 (CCND1) in neuroblastomaJan J Molenaar, Peter van Sluis, Kathy Boon, et al.
Endocrinology|August 29, 2006
Regulation of type III iodothyronine deiodinase expression in human cell linesMonique H A Kester, George G J M Kuiper, Rogier Versteeg, et al.
Cancer Research|January 14, 2010
Silencing of SPRY1 triggers complete regression of rhabdomyosarcoma tumors carrying a mutated RAS geneGerben Schaaf, Mohamed Hamdi, Danny Zwijnenburg, et al.
Plos One|October 22, 2011
Joint binding of OTX2 and MYC in promotor regions is associated with high gene expression in medulloblastomaJens Bunt, Nancy E Hasselt, Danny A Zwijnenburg, et al.
European Journal of Cancer (Oxford, England : 1990)|November 18, 2011
Targeted BIRC5 silencing using YM155 causes cell death in neuroblastoma cells with low ABCB1 expressionFieke Lamers, Linda Schild, Jan Koster, et al.
Acta Neuropathologica|November 27, 2012
OTX2 sustains a bivalent-like state of OTX2-bound promoters in medulloblastoma by maintaining their H3K27me3 levelsJens Bunt, Nancy A Hasselt, Danny A Zwijnenburg, et al.
Cancer Research|February 5, 2013
FOXO3a is a major target of inactivation by PI3K/AKT signaling in aggressive neuroblastomaEvan E Santo, Peter Stroeken, Peter V Sluis, et al.
Cancer Research|April 19, 2005
Inhibition of a new differentiation pathway in neuroblastoma by copy number defects of N-myc, Cdc42, and nm23 genesLinda J Valentijn, Arjen Koppen, Ronald van Asperen, et al.
Nucleic Acids Research|April 12, 2007
Comparison of RNAi efficiency mediated by tetracycline-responsive H1 and U6 promoter variants in mammalian cell linesJørn R Henriksen, Cecilie Løkke, Martin Hammerø, et al.
Pageof 15